Published in Drug Metab Dispos on January 01, 1997
Pharmacogenetic Morphine Spine Study | NCT01839461
Patient Controlled Analgesia Pharmacogenetic Study | NCT01731873
Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest (1998) 2.62
Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut (2002) 1.74
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. Clin Pharmacokinet (2004) 1.51
Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model. Environ Health Perspect (2008) 1.29
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacol Rev (2011) 1.26
Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci U S A (2005) 1.14
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res (2004) 1.12
Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases. Drug Metab Dispos (2011) 1.11
Fatal and severe codeine intoxication in 3-year-old twins--interpretation of drug and metabolite concentrations. Int J Legal Med (2009) 1.03
Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases. J Pharmacol Exp Ther (2007) 1.01
Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. Eur J Clin Pharmacol (2006) 1.01
Increased clearance of morphine in sickle cell disease: implications for pain management. J Pain (2011) 0.98
Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. Eur J Pharm Biopharm (2009) 0.96
Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol (2013) 0.95
Role of active metabolites in the use of opioids. Eur J Clin Pharmacol (2008) 0.91
Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. Front Genet (2012) 0.90
From pediatric covariate model to semiphysiological function for maturation: part I-extrapolation of a covariate model from morphine to Zidovudine. CPT Pharmacometrics Syst Pharmacol (2012) 0.88
The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. Eur J Clin Pharmacol (2009) 0.88
From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part II-Sensitivity to Physiological and Physicochemical Properties. CPT Pharmacometrics Syst Pharmacol (2012) 0.87
OCT1 genetic variants influence the pharmacokinetics of morphine in children. Pharmacogenomics (2013) 0.87
Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis. J Pharmacol Exp Ther (2014) 0.85
A perspective on efflux transport proteins in the liver. Clin Pharmacol Ther (2012) 0.84
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol (2013) 0.84
Options for treating postherpetic neuralgia in the medically complicated patient. Ther Clin Risk Manag (2013) 0.81
Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids. Br J Clin Pharmacol (2006) 0.80
Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences. AAPS J (2014) 0.78
Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome. Br J Clin Pharmacol (2003) 0.78
Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients. Eur J Clin Pharmacol (2012) 0.78
Molecular cloning of the baboon UDP-glucuronosyltransferase 2B gene family and their activity in conjugating morphine. Drug Metab Dispos (2010) 0.78
Dextromethorphan differentially affects opioid antinociception in rats. Br J Pharmacol (2005) 0.78
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain. Eur J Clin Pharmacol (2012) 0.78
Update on prescription extended-release opioids and appropriate patient selection. J Multidiscip Healthc (2013) 0.77
Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat. Br J Pharmacol (2015) 0.77
The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo. Eur J Clin Pharmacol (2013) 0.75
Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6∗2, 1A7∗12, 1A8∗3, 1A9∗3, 2B7∗2, and 2B15∗2) in a Saudi population. Saudi Pharm J (2016) 0.75
Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium. J Clin Pharmacol (2016) 0.75
Neurobiological Effects of Morphine after Spinal Cord Injury. J Neurotrauma (2016) 0.75
Application of photoaffinity labeling with [(3)H] all trans- and 9-cis-retinoic acids for characterization of cellular retinoic acid--binding proteins I and II. Protein Sci (2001) 0.75
Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest (1998) 2.62
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55
Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nat Genet (1994) 2.46
UDP-glucuronosyltransferases. Curr Drug Metab (2000) 1.94
The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos (1998) 1.58
Consequences of neural asynchrony: a case of auditory neuropathy. J Assoc Res Otolaryngol (2000) 1.55
Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis. Am J Med (1980) 1.49
Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase. Biochem J (1979) 1.46
Methanol poisoning: ocular toxicity produced by formate. Toxicol Appl Pharmacol (1978) 1.42
The effect of cobalt chloride administration on the synthesis of hepatic microsomal cytochrome P-450. Biochem Biophys Res Commun (1971) 1.41
Effect of 3-amino-1,2,4-triazole on the stimulation of hepatic microsomal heme synthesis and induction of hepatic microsomal oxidases produced by phenobarbital. Mol Pharmacol (1969) 1.35
Separation, purification and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes. Arch Biochem Biophys (1983) 1.31
Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics (1997) 1.31
Prostaglandin influences on intraocular pressure and pupil size. Am J Physiol (1967) 1.28
Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol (1999) 1.24
3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos (2000) 1.20
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
Morphine metabolism. III. Solubilization and separation of morphine and p-nitrophenol uridine diphosphoglucuronyltransferases. Mol Pharmacol (1975) 1.13
Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis. Arthritis Rheum (2012) 1.12
Temperature measurement in term and preterm neonates. J Pediatr (1984) 1.12
Effect of drugs on heme synthesis in the liver. Metabolism (1971) 1.12
4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem (2000) 1.11
Outreach services: issues and challenges. Med Ref Serv Q (1997) 1.11
Methyl alcohol poisoning III. Ocular toxicity. Arch Ophthalmol (1977) 1.10
Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos (1996) 1.10
Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes. J Clin Invest (1987) 1.09
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos (1998) 1.09
Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Drug Metab Dispos (1998) 1.06
Identification of N-methylprotoporphyrin IX in livers of untreated mice and mice treated with 3, 5-diethoxycarbonyl- 1, 4-dihydrocollidine: source of the methyl group. Arch Biochem Biophys (1981) 1.06
Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos (1995) 1.05
Morphine metabolism. I. Evidence for separate enzymes in the glucuronidation of morphine and p-nitrophenol by rat hepatic microsomes. Drug Metab Dispos (1974) 1.05
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J Pharmacol Exp Ther (2010) 1.04
Methanol poisoning. V. Role of formate metabolism in the monkey. J Pharmacol Exp Ther (1977) 1.03
The regulation of heme synthesis related to drug metabolism. Drug Metab Dispos (1974) 1.02
Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos (1995) 1.02
Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase. Biochem J (1986) 1.02
Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor. Biochem J (1980) 1.02
Methyl alcohol poisoning. IV. Alterations of the morphological findings of the retina and optic nerve. Arch Ophthalmol (1977) 1.02
Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. Drug Metab Dispos (1999) 1.01
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis (1999) 1.01
Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7. Toxicol Sci (1998) 1.00
Further studies on the relationship of the stimulatory effects of phenobarbital and 3,4-benzpyrene on hepatic heme synthesis to their effects on hepatic microsomal drug oxidations. Arch Biochem Biophys (1970) 1.00
Separation of oestrone UDP-glucuronyltransferase and p-nitrophenol UDP-glucuronyltransferase activities. Biochem J (1978) 0.99
The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys (1996) 0.99
Formate assay in body fluids: application in methanol poisoning. Biochem Med (1975) 0.97
Improved estimation of formate in body fluids and tissues. Clin Chem (1982) 0.96
Methyl alcohol poisoning. II. Development of a model for ocular toxicity in methyl alcohol poisoning using the rhesus monkey. Arch Ophthalmol (1977) 0.96
Double sotope scintiphotography for differentiating between renal cysts and renal tumors. J Urol (1967) 0.96
Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys (1999) 0.95
UDP-glucuronosyltransferases in human intestinal mucosa. Biochim Biophys Acta (1998) 0.94
Formaldehyde poisoning. Rapid metabolism to formic acid. JAMA (1981) 0.94
Glucuronidation of bile acids by rat liver 3-OH androgen UDP-glucuronyltransferase. J Biol Chem (1984) 0.94
High-pressure liquid chromatography separation and determination of rat liver folates. Arch Biochem Biophys (1981) 0.93
Morphine metabolism. II. Studies on morphine glucuronyltransferase activity in intestinal microsomes of rats. Drug Metab Dispos (1974) 0.92
Methanol toxicity: treatment with folic acid and 5-formyl tetrahydrofolic acid. Alcohol Clin Exp Res (1980) 0.92
Methanol poisoning. I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole. Biochem Med (1975) 0.91
The role of hepatic microbody and soluble oxidases in the peroxidation of methanol in the rat and monkey. Mol Pharmacol (1968) 0.91
The role of heme synthesis during the induction of hepatic microsomal cytochrome P-450 and drug metabolism produced by benzpyrene. Biochem Biophys Res Commun (1969) 0.91
The enzymatic mechanism of glucuronidation catalyzed by two purified rat liver steroid UDP-glucuronosyltransferases. J Biol Chem (1987) 0.90
Studies on the mechanism of methanol poisoning: purification and comparison of rat and human liver 10-formyltetrahydrofolate dehydrogenase. Mol Pharmacol (1989) 0.90
Methanol poisoning and formate oxidation in nitrous oxide-treated rats. J Pharmacol Exp Ther (1981) 0.90
Morphine metabolism. V. Isolation of separate glucuronyltransferase activities for morphine and p-nitrophenol from rabbit liver microsomes. Drug Metab Dispos (1977) 0.90
Steroid 3- and 17-OH UDP-glucuronosyltransferase activities in rat and rabbit liver microsomes. Drug Metab Dispos (1983) 0.90
Folate and 10-formyltetrahydrofolate dehydrogenase (FDH) expression in the central nervous system of the mature rat. Brain Res (1997) 0.89
Isolation and purification of two human liver UDP-glucuronosyltransferases. Mol Pharmacol (1987) 0.89
Purification of properties of rabbit liver estrone and p-nitrophenol UDP-glucuronyltransferases. Arch Biochem Biophys (1981) 0.89
Studies on methanol toxicity and formate metabolism in isolated hepatocytes. The role of methionine in folate-dependent reactions. Biochem Pharmacol (1979) 0.88
Blood methanol concentrations in normal adult subjects administered abuse doses of aspartame. J Toxicol Environ Health (1981) 0.88
Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. Arch Biochem Biophys (1998) 0.88
Role of hepatic tetrahydrofolate in the species difference in methanol toxicity. Proc Natl Acad Sci U S A (1985) 0.87
UDP glucuronosyltransferase in the cirrhotic rat liver. J Gastroenterol Hepatol (1996) 0.86
Methanol toxicity in the monkey: effects of nitrous oxide and methionine. J Pharmacol Exp Ther (1983) 0.86
Air versus skin temperature servocontrol of infant incubators. J Pediatr (1983) 0.86
Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab Dispos (1997) 0.86
Substrate specificity and characterization of rat liver p-nitrophenol, 3 alpha-hydroxysteroid and 17 beta-hydroxysteroid UDP-glucuronosyltransferases. Biochem J (1986) 0.86
Lack of a role for formaldehyde in methanol poisoning in the monkey. Biochem Pharmacol (1979) 0.86
delta-Aminolevulinic acid synthetase-sensitive methods in liver for hemoprotein biosynthesis. Methods Enzymol (1978) 0.86
Inhibition of drug metabolism. V. Inhibition of drug metabolism by steroids. Mol Pharmacol (1968) 0.86
The role of substrates for glycine acyltransferase, and the role of sulfanilamide and acetate in the reversal of chemically-induced porphyria in the rat. Enzyme (1973) 0.85
The role of methionine in regulating folate-dependent reactions in isolated rat hepatocytes. Arch Biochem Biophys (1981) 0.85
Isolation and purification of rat liver morphine UDP-glucuronosyltransferase. Mol Pharmacol (1986) 0.84
The formation of N-alkylprotoporphyrin IX and destruction of cytochrome P-450 in the liver of rats after treatment with 3,5-diethoxycarbonyl-1,4-dihydrocollidine and its 4-ethyl analog. Arch Biochem Biophys (1982) 0.84
Methanol poisoning in the folate-deficient rat. Nature (1976) 0.84
The pharmacology of rapid eye movement sleep. Adv Pharmacol Chemother (1971) 0.84
Phospholipid-dependence of oestrone UDP-glucuronyltransferase and p-nitrophenol UDP-glucuronyltransferase. Biochem J (1979) 0.84
Structural requirements in the reaction of morphine uridine diphosphate glucuronyltransferase with opioid substances. Biochem J (1978) 0.84
Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomes. Drug Metab Dispos (2000) 0.83
Metabolism of formate in the rat. J Toxicol Environ Health (1975) 0.83
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP). Clin Pharmacol Ther (2010) 0.83